The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Looks like the market doesn’t like today’s rns! If we’re all being honest, the only rns that matters and the one the market will take note of is the rns that states how high the sensitivity and specificity is of the saliva test! Until the sp will continue to stagnate. Here’s to hoping we hear this week we have the best in class saliva test. Gl all
Flying on both sides of the Atlantic!
The problem you’ve got is AS talked this up which inflated the price and the market aren’t happy they still haven’t a product to market. No one really cares about the BAMS test as AS talked up the LFT as game changing, problem being, no real news on the product that took the sp to an all time high! The market seems to be thinking it’s all smoke an mirrors, which after the placing and the subsequent majority put aside for the cancer treatment I completely understand why the sp has taken a hammering! Im currently 13% up on my investment along way away from the 120% 2 weeks ago!! See what happens first thing tomorrow and if it plummets I’ll be left with no choice to protect capital!
Myles went silent for a few day! Rk is a top poster, his research and post are very informative would just be interested in his view on the placing. Anyway 4 minutes till open! I’m switching off and logging back on at 4.31 so won’t be tempted to sell. Gla